SYSTEMS PHARMACOLOGY AND MOLECULAR NETWORK MECHANISMS OF STANDARDIZED EXTRACTS OF TRICHOSANTHES DIOICA ROXB. IN GASTROPROTECTION: A TRANSLATIONAL REVIEW TOWARD PRECISION PHYTOTHERAPY

*Devanssh Mehta

Peptic ulcer disease (PUD) is a multifactorial gastrointestinal disorder characterized by disruption of mucosal integrity due to an imbalance between aggressive luminal factors and endogenous defense systems. Contemporary pharmacotherapy—dominated by proton pump inhibitors and H₂ receptor antagonists—has achieved symptomatic control; however, issues of relapse, microbial resistance, and long-term adverse effects necessitate exploration of multi-targeted phytotherapeutics. Trichosanthes dioica Roxb. (Cucurbitaceae), an ethnomedicinally significant plant of the Indian subcontinent, has emerged as a promising gastroprotective agent owing to its diverse phytochemical repertoire and pleiotropic biological activities. This review provides a rigorously structured synthesis of the molecular pathways underlying the antiulcer efficacy of standardized extracts of T. dioica, integrating phytochemistry, experimental pharmacology, and systems biology. Mechanistic evidence indicates that T. dioica exerts gastroprotection through coordinated modulation of oxidative stress (Nrf2–ARE signaling), inflammatory cascades (NF-κB suppression), gastric acid secretion (H⁺/K⁺-ATPase inhibition), and cytoprotective mediators including prostaglandins and nitric oxide. The presence of flavonoids, triterpenoids, saponins, and tannins contributes to redox homeostasis, membrane stabilization, and mucosal regeneration. Furthermore, emerging paradigms in network pharmacology and nano-phytopharmaceuticals are redefining its translational potential, enabling enhanced bioavailability, target specificity, and therapeutic precision. By aligning classical herbal knowledge with modern molecular insights, this review advances T. dioica as a viable candidate for next-generation gastroprotective drug development within a precision medicine framework.